WELCOME TO The PHARMACEUTICAL REPORT
Tackling Clinical Trial Data Overload with Data Lakes and Machine Learning
October 31, 2019
I'm For Real
Enter your details once to access all our information and resources
Stallergenes Greer is a global biopharmaceutical company specializing in the diagnosis and treatment of respiratory allergies through the development and commercialization of Allergy Immunotherapy products and services.
whitePaper | March 6, 2022
Pharmaceutical companies with a medical mindset and an empowered Medical Afairs function are well equipped to meet the needs and expectations of patients and society. Yet, as capacity to understand and serve those needs accelerates.
whitePaper | June 27, 2022
As the world begins its transition into a postpandemic existence, it becomes possible to look back on the past two years and begin to quantify the effects that COVID-19 has brought.
whitePaper | July 7, 2022
The full drug target profile identification is many times a necessary step in drug development process. Recently, the move to a more holistic approach in drug discovery has resulted in the increasing use of cell-based assays to discover new biologically active small molecules.
whitePaper | April 1, 2021
Every year, the U.S. pharmaceutical industry develops
a variety of new drugs that provide valuable medical
benefits. Many of those drugs are expensive and contribute to rising health care costs for the private sector and
the federal government. Policymakers have considered
policies that would lower drug prices and reduce federal
drug expenditures. Such policies would probably reduce
the industry’s incentive to develop new drugs.
whitePaper | July 29, 2021
As pharma companies strive for increased commercial success the customer-centric focus can get lost in the adoption of new commercial endeavours. As a result, many have been looking toward the world of design as a way of enhancing their customer engagement and accelerating their position in the market.
whitePaper | November 25, 2019
It's clear that healthcare prices weigh heavily on the minds of Americans, and the time has come for the pharmaceutical industry to take the reins of the prescription drug pricing dialogue with consumers.
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE